FOLFIRINOX + NIS793 in Pancreatic Cancer
Phase 1 Terminated
4 enrolled
First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC
Phase 2 Terminated
1 enrolled
A Study of Tislelizumab Combined With Radiotherapy as the Second-line Treatment of Advanced Biliary Malignant Tumors
Phase 2 Terminated
20 enrolled
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
Phase 1 Terminated
1 enrolled 7 charts
Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT
Phase 3 Terminated
36 enrolled
SBRTvsTACE
Phase 3 Terminated
9 enrolled 7 charts
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
Phase 1 Terminated
3 enrolled 9 charts
Ipilimumab and Local Radiation for Selected Solid Tumors
Phase 1 Terminated
3 enrolled 5 charts
Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer
Phase 2 Terminated
11 enrolled 11 charts
Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas
Phase 2 Terminated
9 enrolled 12 charts
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Terminated
22 enrolled 5 charts
RECAP
Phase 1 Terminated
25 enrolled
OLGA
Phase 2 Terminated
1 enrolled
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
Phase 2 Terminated
137 enrolled 9 charts
Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer
Phase 3 Terminated
49 enrolled
A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer
Phase 1/2 Terminated
32 enrolled
Perioperative Therapy for Hepatocellular Carcinoma
Phase 2 Terminated
10 enrolled
A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum
Phase 1 Terminated
1 enrolled 7 charts
Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
Phase 1 Terminated
6 enrolled 28 charts
TRENDY
Phase 2 Terminated
100 enrolled
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
Phase 1/2 Terminated
32 enrolled 18 charts
Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
Phase 2 Terminated
4 enrolled
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
Phase 2 Terminated
19 enrolled
A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas
Phase 2 Terminated
10 enrolled 4 charts
J10130
Phase 2 Terminated
31 enrolled 11 charts
Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
Phase 2 Terminated
19 enrolled 4 charts
Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Phase 1 Terminated
4 enrolled 7 charts
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC
Phase 2 Terminated
6 enrolled 12 charts
Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery
Phase 1 Terminated
2 enrolled
Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy
Phase 2 Terminated
1 enrolled 5 charts
ADAPT
Phase 2 Terminated
27 enrolled 10 charts
Chemoradiation in Locally Advanced Pancreatic Cancer
Phase 2 Terminated
23 enrolled 8 charts
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Phase 1/2 Terminated
23 enrolled 18 charts
NEOMETRE
Phase 2 Terminated
3 enrolled
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
Phase 2 Terminated
5 enrolled 6 charts
Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
Phase 2 Terminated
7 enrolled 8 charts
Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas
Phase 1/2 Terminated
10 enrolled 12 charts
LOTCOL
Phase NA Terminated
3 enrolled
Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
Phase 2 Terminated
3 enrolled
PERU
Phase 2 Terminated
17 enrolled
Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
Phase 2 Terminated
27 enrolled 6 charts
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
Phase 2 Terminated
12 enrolled 8 charts
Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy
Phase 2 Terminated
5 enrolled 6 charts
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Phase 2 Terminated
22 enrolled 9 charts
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer
Phase 1/2 Terminated
3 enrolled
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
Phase 1/2 Terminated
Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
Phase 2/3 Terminated
88 enrolled
Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery
Phase NA Terminated
12 enrolled
S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery
Phase 2 Terminated
7 enrolled 7 charts